NPs Basic Information

Name
Dehydroxypaxilline
Molecular Formula C27H33NO3
IUPAC Name*
(1S,2S,5S,7R,11R,14S)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-9,16(24),17,19,21-pentaen-8-one
SMILES
C[C@]12CC[C@H]3C(=CC(=O)[C@H](O3)C(C)(C)O)[C@@H]1CC[C@@H]4[C@@]2(C5=C(C4)C6=CC=CC=C6N5)C
InChI
InChI=1S/C27H33NO3/c1-25(2,30)24-21(29)14-18-19-10-9-15-13-17-16-7-5-6-8-20(16)28-23(17)27(15,4)26(19,3)12-11-22(18)31-24/h5-8,14-15,19,22,24,28,30H,9-13H2,1-4H3/t15-,19-,22-,24-,26-,27+/m0/s1
InChIKey
GYSZYWSJZCKCBD-LXGUAGHKSA-N
Synonyms
13-Desoxypaxilline; DEHYDROXYPAXILLINE; 13-Deoxypaxilline; 13-dehydroxypaxilline; CHEMBL2408948; CHEBI:187070; DTXSID901099217; C20531; (1S,2S,5S,7R,11R,14S)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-9,16(24),17,19,21-pentaen-8-one; (2R,4bR,6aS,12bS,12cS,14aS)-5,6,6a,7,12,12b,12c,13,14,14a-Decahydro-2-(1-hydroxy-1-methylethyl)-12b,12c-dimethyl-2H-1-benzopyrano[5',6':6,7]indeno[1,2-b]indol-3(4bH)-one; 112900-05-7
CAS 112900-05-7
PubChem CID 14166134
ChEMBL ID CHEMBL2408948
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Naphthopyrans
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Naphthopyrans

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 419.6 ALogp: 4.9
HBD: 2 HBA: 3
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 62.3 Aromatic Rings: 6
Heavy Atoms: 31 QED Weighted: 0.665

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.951 MDCK Permeability: 0.00002710
Pgp-inhibitor: 0.841 Pgp-substrate: 0.64
Human Intestinal Absorption (HIA): 0.007 20% Bioavailability (F20%): 0.012
30% Bioavailability (F30%): 0.933

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.865 Plasma Protein Binding (PPB): 94.96%
Volume Distribution (VD): 0.854 Fu: 2.51%

ADMET: Metabolism

CYP1A2-inhibitor: 0.246 CYP1A2-substrate: 0.611
CYP2C19-inhibitor: 0.337 CYP2C19-substrate: 0.681
CYP2C9-inhibitor: 0.641 CYP2C9-substrate: 0.258
CYP2D6-inhibitor: 0.24 CYP2D6-substrate: 0.138
CYP3A4-inhibitor: 0.95 CYP3A4-substrate: 0.798

ADMET: Excretion

Clearance (CL): 7.357 Half-life (T1/2): 0.2

ADMET: Toxicity

hERG Blockers: 0.021 Human Hepatotoxicity (H-HT): 0.245
Drug-inuced Liver Injury (DILI): 0.534 AMES Toxicity: 0.221
Rat Oral Acute Toxicity: 0.915 Maximum Recommended Daily Dose: 0.896
Skin Sensitization: 0.759 Carcinogencity: 0.847
Eye Corrosion: 0.007 Eye Irritation: 0.017
Respiratory Toxicity: 0.985
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002951 0.773 D01JGV 0.296
ENC005989 0.758 D0U7GP 0.296
ENC003172 0.758 D0H4JM 0.296
ENC005990 0.725 D05MQK 0.267
ENC000836 0.709 D0V4WD 0.257
ENC005988 0.705 D0U3GL 0.254
ENC005406 0.673 D0K0KH 0.254
ENC005405 0.670 D00YLW 0.246
ENC001492 0.600 D06AEO 0.244
ENC000857 0.596 D0Q6NZ 0.244
*Note: the compound similarity was calculated by RDKIT.